Related Experiment Video

Updated: Jul 26, 2026

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

Thoracoscopic thymectomy for myasthenia gravis in children

K A Kogut1, A J Bufo, S S Rothenberg

  • 1University of Tennessee, Memphis, LeBonheur Children's Medical Center, 38105, USA.

Journal of Pediatric Surgery
|November 18, 2000
PubMed

Insights

Thoracoscopic procedures in children are described, showing an average operating time under two hours. This minimally invasive technique appears safe and effective for pediatric patients.

Area of Science:

  • Pediatric surgery
  • Thoracic surgery
  • Minimally invasive procedures

Background:

  • Thoracoscopic surgery offers potential benefits for pediatric patients.
  • Establishing safe and effective techniques is crucial in pediatric thoracic procedures.

Purpose of the Study:

  • To describe the technique for thoracoscopic procedures in children.
  • To evaluate the safety and efficacy of this surgical approach.

Main Methods:

  • Description of the thoracoscopic surgical technique adapted for pediatric use.
  • Analysis of operative time and patient outcomes.

Main Results:

  • The average operative time for thoracoscopic procedures in children was under 2 hours.
  • The technique was found to be safe and effective in the pediatric population.

Conclusions:

  • Thoracoscopic surgery is a viable and safe option for pediatric thoracic conditions.
  • The described technique facilitates efficient and effective surgical intervention in children.

More Related Videos

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...